Transcend

Transcend

The purpose of the study is to evaluate the safety and efficacy of the SurVeil DCB for treatment of subjects with symptomatic peripheral artery disease (PAD) due to stenosis of the femoral and/or popliteal arteries.

Please use this link for further information:

Primary Investigator: Sashi Kilaru

Follow up only

Disclaimer: Patients must have an existing, documented diagnosis to be entered into some trials.
Copyright © 2024 All rights reserved.

Web Design by TBH Creative